Klabunde Thomas相关文献与解析，生知库 | 链接生命科学的每一步

Wehling, Lilija; Singh, Gurdeep; Mulyadi, Ahmad Wisnu; Sreenath, Rakesh Hadne; Hermjakob, Henning; Nguyen, Tung V N; Rückle, Thomas; Mosa, Mohammed H; Cordes, Henrik; Andreani, Tommaso; Klabunde, Thomas; Malik Sheriff, Rahuman S; McCloskey, Douglas

发表日期：2025

文献求助收藏

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide

与利拉鲁肽相比，双重胰高血糖素样肽-1/胰高血糖素受体激动剂SAR425899可改善2型糖尿病患者的餐后血糖代谢。

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14394

Schiavon, Michele; Visentin, Roberto; Göbel, Britta; Riz, Michela; Cobelli, Claudio; Klabunde, Thomas; Dalla Man, Chiara

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

计算机模拟对胰岛素甘精300 U/mL和胰岛素德谷100 U/mL在1型糖尿病中的疗效进行直接比较

期刊:Diabetes Technology & Therapeutics

影响因子:6.3

doi:10.1089/dia.2020.0027

Schiavon, Michele; Visentin, Roberto; Giegerich, Clemens; Sieber, Jochen; Dalla Man, Chiara; Cobelli, Claudio; Klabunde, Thomas

Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion.

葡萄糖调节和药物扰动的磷酸化蛋白质组揭示了控制胰岛素分泌的分子机制

期刊:Nature Communications

影响因子:15.7

doi:10.1038/ncomms13250

Sacco Francesca, Humphrey Sean J, Cox JÃ¼rgen, Mischnik Marcel, Schulte Anke, Klabunde Thomas, SchÃ¤fer Matthias, Mann Matthias

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

通过餐后给药提高吸入式 Technosphere 胰岛素（Afrezza）的疗效：弗吉尼亚大学/帕多瓦大学 1 型糖尿病模拟器的计算机模拟临床试验

期刊:Diabetes Technology & Therapeutics

影响因子:6.3

doi:10.1089/dia.2016.0128

Visentin, Roberto; Giegerich, Clemens; Jäger, Robert; Dahmen, Raphael; Boss, Anders; Grant, Marshall; Dalla Man, Chiara; Cobelli, Claudio; Klabunde, Thomas

Talk2Biomodels: AI agent-based open-source LLM initiative for kinetic biological models

Talk2Biomodels：面向动力学生物模型的基于人工智能代理的开源LLM计划

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide

与利拉鲁肽相比，双重胰高血糖素样肽-1/胰高血糖素受体激动剂SAR425899可改善2型糖尿病患者的餐后血糖代谢。

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

计算机模拟对胰岛素甘精300 U/mL和胰岛素德谷100 U/mL在1型糖尿病中的疗效进行直接比较

Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion.

葡萄糖调节和药物扰动的磷酸化蛋白质组揭示了控制胰岛素分泌的分子机制

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

通过餐后给药提高吸入式 Technosphere 胰岛素（Afrezza）的疗效：弗吉尼亚大学/帕多瓦大学 1 型糖尿病模拟器的计算机模拟临床试验